Eylea



Indications and Reactions:

Role Indications Reactions
Primary
Age-related Macular Degeneration 81.2%
Macular Degeneration 11.1%
Exudative Senile Macular Degeneration Of Retina 1.8%
Choroidal Neovascularisation 1.5%
Rectosigmoid Cancer 0.9%
Wet Macular Degeneration 0.9%
Central Retinal Vein Occlusion 0.3%
Erectile Dysfunction 0.3%
Exudative Senile Macular Degenerative Of Retina 0.3%
Hypertension 0.3%
Polypoidal Choroidal Vasculopathy 0.3%
Pre-existing Condition Improved 0.3%
Retinal Degeneration 0.3%
Retinal Vein Occlusion 0.3%
Wet Macular Degeneration 0.3%
Visual Acuity Reduced 19.0%
Death 15.7%
Vitritis 7.8%
Retinal Haemorrhage 7.1%
Vitreous Floaters 7.1%
Uveitis 6.3%
Endophthalmitis 5.2%
Cerebrovascular Accident 3.0%
Eye Inflammation 3.0%
Myocardial Infarction 3.0%
Vision Blurred 3.0%
Eye Haemorrhage 2.6%
Visual Impairment 2.6%
Anterior Chamber Inflammation 2.2%
Blindness 2.2%
Vitrectomy 2.2%
Vitreous Opacities 2.2%
Eye Pain 1.9%
Macular Oedema 1.9%
Non-infectious Endophthalmitis 1.9%
Secondary
Age-related Macular Degeneration 57.5%
Product Used For Unknown Indication 27.5%
Diabetic Vascular Disorder 5.0%
Macular Degeneration 5.0%
Wet Macular Degeneration 5.0%
Visual Acuity Reduced 25.8%
Death 16.1%
Cerebrovascular Accident 12.9%
Macular Fibrosis 6.5%
Pseudoendophthalmitis 6.5%
Anterior Chamber Inflammation 3.2%
Corneal Disorder 3.2%
Deep Vein Thrombosis 3.2%
Endophthalmitis 3.2%
Haemorrhage 3.2%
Non-infectious Endophthalmitis 3.2%
Rash 3.2%
Retinal Detachment 3.2%
Transient Ischaemic Attack 3.2%
Vitreous Opacities 3.2%
Concomitant
Age-related Macular Degeneration 27.3%
Eye Disorder 13.6%
Chronic Obstructive Pulmonary Disease 9.1%
Depression 9.1%
Macular Degeneration 9.1%
Chorioretinopathy 4.5%
Glaucoma 4.5%
Hypothyroidism 4.5%
Major Depression 4.5%
Open Angle Glaucoma 4.5%
Product Used For Unknown Indication 4.5%
Vitamin D Decreased 4.5%
Cerebrovascular Accident 22.2%
Anterior Chamber Cell 11.1%
Retinal Haemorrhage 11.1%
Transient Ischaemic Attack 11.1%
Underdose 11.1%
Vision Blurred 11.1%
Visual Acuity Reduced 11.1%
Weight Decreased 11.1%